1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Insulin Pump Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Insulin Pump Market, by Pump Type
8.1.1. Tethered Pump
8.1.1.1. Market Revenue and Forecast
8.1.2. Patch Pump
8.1.2.1. Market Revenue and Forecast
9.1. U.S. Insulin Pump Market, by Application
9.1.1. Battery
9.1.1.1. Market Revenue and Forecast
9.1.2. Insulin Set Insertion Devices
9.1.2.1. Market Revenue and Forecast
9.1.3. Insulin Reservoir
9.1.3.1. Market Revenue and Forecast
10.1. U.S. Insulin Pump Market, by Disease Indication Type
10.1.1. Type 1 Diabetes
10.1.1.1. Market Revenue and Forecast
10.1.2. Type 2 Diabetes
10.1.2.1. Market Revenue and Forecast
11.1. U.S. Insulin Pump Market, by End User Type
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Homecare
11.1.3.1. Market Revenue and Forecast
11.1.4. Laboratories
11.1.4.1. Market Revenue and Forecast
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Pump
12.1.5.2. Market Revenue and Forecast, by Application
12.1.5.3. Market Revenue and Forecast, by Disease Indication Type
12.1.5.4. Market Revenue and Forecast, by End User Type
13.1. Medtronic Plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Insulet Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Medzer
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Microport Scientific
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Eoflow
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Debiotech S.A.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Lenomed Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Microtech Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cequr SA
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. F. Hoffmann La Roche AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Ypsomed AG
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
